ENVERIC BIOSCIENCES, INC. Stock Issued During Period, Value, Stock Dividend
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, stock dividend for the quarter ending 2018-12-31 was $104.66K.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, stock dividend for fiscal 2018 was $766.21K, a 63.32% decline from fiscal 2017.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, stock dividend for fiscal 2017 was $2.09M.
| Period end | Stock Issued During Period, Value, Stock Dividend 3 month | Stock Issued During Period, Value, Stock Dividend 12 month |
|---|---|---|
| 2018-12-31 | $104.66K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-12 | $766.21K 10-K/A · filed 2020-08-12 |
| 2017-12-31 | $2.09M 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |